Evidence map›Paper›PMID 29426838›Full record

ArticleScientific reports2018

Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development.

Huai-Chin Chiang, Xiaowen Zhang, Xiayan Zhao, Chi Zhang, Jerry Chen, Paula Garza, Sabrina Smith, Thomas Ludwig, Richard J Baer, Rong Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Huai-Chin ChiangDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.
Xiaowen ZhangDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.
Xiayan ZhaoXiangya School of Medicine, Central South University, Changsha, Hunan, China.
Chi ZhangDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.ORCID 0000-0002-0766-8770
Jerry ChenDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.
Paula GarzaDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.
Sabrina SmithDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.
Thomas LudwigDepartment of Cancer Biology and Genetics, Ohio State University, Columbus, OH, 43210, USA.
Richard J BaerDepartment of Pathology & Cell Biology, New York, NY, 10032, USA.
Rong LiDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA. lir3@uthscsa.edu.
Yanfen HuDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA. huy3@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · USCentral South University · CNThe Ohio State University · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Cancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3M
Crosstalk between BRCA1 and Transcription in Breast CancerR01CA220578 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LI, RONG · 2017 to 2022
$2.1M
Role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenanceR01CA212674 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HU, YANFEN, LI, RONG · 2017 to 2022
$1.9M
NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA212674NCI NIH HHS R01 CA220578NCI NIH HHS T32 CA148724
6 · The paper itself

Abstract

Germ-line mutations in breast cancer susceptibility gene, BRCA1, result in familial predisposition to breast and ovarian cancers. The BRCA1 protein has multiple functional domains that interact with a variety of proteins in multiple cellular processes. Understanding the biological consequences of BRCA1 interactions with its binding partners is important for elucidating its tissue-specific tumor suppression function. The Cofactor of BRCA1 (COBRA1) is a BRCA1-binding protein that, as a component of negative elongation factor (NELF), regulates RNA polymerase II pausing during transcription elongation. We recently identified a genetic interaction between mouse Brca1 and Cobra1 that antagonistically regulates mammary gland development. However, it remains unclear which of the myriad functions of Brca1 are required for its genetic interaction with Cobra1. Here, we show that, unlike deletion of Brca1 exon 11, separation-of-function mutations that abrogate either the E3 ligase activity of its RING domain or the phospho-recognition property of its BRCT domain are not sufficient to rescue the mammary developmental defects in Cobra1 knockout mice. Furthermore, deletion of mouse Palb2, another breast cancer susceptibility gene with functional similarities to BRCA1, does not rescue Cobra1 knockout-associated mammary defects. Thus, the Brca1/Cobra1 genetic interaction is both domain- and gene-specific in the context of mammary gland development.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsBRCA1 ProteinFanconi Anemia Complementation Group N ProteinFemaleGenetic Complementation TestMammary Glands, AnimalMiceMice, KnockoutNuclear ProteinsRNA-Binding ProteinsTumor Suppressor ProteinsBRCA1 ProteinBrca1 protein, mouseCobra1 protein, mouseFanconi Anemia Complementation Group N ProteinNuclear ProteinsPalb2 protein, mouseRNA-Binding ProteinsTumor Suppressor Proteins

Identifiers

PMID29426838
PMCPMC5807304
OpenAlexW2807180788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.